Radioterapia ipofrazionata short-course neoadiuvante in associazione alla chemioterapia nelle neoplasie rettali operabili in stadio localmente avanzato: Controllo locale e qualità di vita

Translated title of the contribution: Short-course preoperative radiotherapy combined with chemotherapy in resectable locally advanced rectal cancer: Local control and quality of life

Patrizia Ciammella, Maria Paola Ruggieri, Maria Galeandro, Nunziata D'Abbiero, Alessandro Giunta, Cinzia Iotti

Research output: Contribution to journalArticle

Abstract

Purpose. The authors sought to evaluate the clinical outcome after preoperative short-course radiotherapy (SCRT) for locally advanced resectable rectal cancer in terms of local control (LC) and quality of life (QoL). Materials and methods. Patients with locally advanced rectal cancer enrolled between 1997 and 2008 in an observational study of preoperative SC-RT were analysed. The treatment algorithm was neo-adjuvant chemotherapy (CT) administered for four cycles, followed by preoperative SC-RT administered 1 week after chemotherapy completion, delivering 20 Gy in five fractions over 1 week. Immediately in the following week surgery was performed. The adjuvant 5-FU-based CT was planned for pathological stage UICC≥II. LC, overall survival (OS), disease-free survival (DFS), early and late complications (RTOG scale) were analysed. All patients completed the EORTC QoL (C-30 and C-38), Faecal Incontinence QoL, and International Index of Erectile Function questionnaires (IIEF). Results. A total of 67 patients were analysed. Chemotherapy and radiotherapy were well tolerated. At the pathological analysis, stable disease was obtained in 24 patients (36%), reduction of disease stage in 34 patients (50.7%), and progression in nine cases (13.3%). Adjuvant chemotherapy was indicated in 21 patients. Two locoregional recurrences, both within the radiotherapy ipovolume, were observed, resulting in a 5-year LC of 97%. The 5-year DFS was 84%, with mean time to systemic progression of 24 months. After a mean follow-up of 114 months, the 5-year OS rate was 67%. Late toxicity >grade II was observed in 9% of patients. High anterior resection (AR) patients had significantly better scores than low AR or abdomino-perineal resection (APR). A total of 89% of the patients treated with conservative surgery had regular anal sphincter function. In male patients undergoing AR or APR, erectile dysfunction was found in 47% and 75% of the cases, respectively. Conclusions. Preoperative SC-RT combined with chemotherapy for locally advanced resectable rectal cancers was well tolerated. This treatment resulted in favourable LC, OS, low rates of toxicity and satisfying QoL.

Original languageItalian
Pages (from-to)1397-1411
Number of pages15
JournalRadiologia Medica
Volume118
Issue number8
DOIs
Publication statusPublished - Dec 2013

Fingerprint

Rectal Neoplasms
Radiotherapy
Quality of Life
Drug Therapy
Adjuvant Chemotherapy
Disease-Free Survival
Survival Rate
Fecal Incontinence
Anal Canal
Erectile Dysfunction
Fluorouracil
Observational Studies
Recurrence
Survival
Therapeutics

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Medicine(all)

Cite this

Radioterapia ipofrazionata short-course neoadiuvante in associazione alla chemioterapia nelle neoplasie rettali operabili in stadio localmente avanzato : Controllo locale e qualità di vita. / Ciammella, Patrizia; Ruggieri, Maria Paola; Galeandro, Maria; D'Abbiero, Nunziata; Giunta, Alessandro; Iotti, Cinzia.

In: Radiologia Medica, Vol. 118, No. 8, 12.2013, p. 1397-1411.

Research output: Contribution to journalArticle

@article{ad61b47a10954395a502a1dc1f411b1b,
title = "Radioterapia ipofrazionata short-course neoadiuvante in associazione alla chemioterapia nelle neoplasie rettali operabili in stadio localmente avanzato: Controllo locale e qualit{\`a} di vita",
abstract = "Purpose. The authors sought to evaluate the clinical outcome after preoperative short-course radiotherapy (SCRT) for locally advanced resectable rectal cancer in terms of local control (LC) and quality of life (QoL). Materials and methods. Patients with locally advanced rectal cancer enrolled between 1997 and 2008 in an observational study of preoperative SC-RT were analysed. The treatment algorithm was neo-adjuvant chemotherapy (CT) administered for four cycles, followed by preoperative SC-RT administered 1 week after chemotherapy completion, delivering 20 Gy in five fractions over 1 week. Immediately in the following week surgery was performed. The adjuvant 5-FU-based CT was planned for pathological stage UICC≥II. LC, overall survival (OS), disease-free survival (DFS), early and late complications (RTOG scale) were analysed. All patients completed the EORTC QoL (C-30 and C-38), Faecal Incontinence QoL, and International Index of Erectile Function questionnaires (IIEF). Results. A total of 67 patients were analysed. Chemotherapy and radiotherapy were well tolerated. At the pathological analysis, stable disease was obtained in 24 patients (36{\%}), reduction of disease stage in 34 patients (50.7{\%}), and progression in nine cases (13.3{\%}). Adjuvant chemotherapy was indicated in 21 patients. Two locoregional recurrences, both within the radiotherapy ipovolume, were observed, resulting in a 5-year LC of 97{\%}. The 5-year DFS was 84{\%}, with mean time to systemic progression of 24 months. After a mean follow-up of 114 months, the 5-year OS rate was 67{\%}. Late toxicity >grade II was observed in 9{\%} of patients. High anterior resection (AR) patients had significantly better scores than low AR or abdomino-perineal resection (APR). A total of 89{\%} of the patients treated with conservative surgery had regular anal sphincter function. In male patients undergoing AR or APR, erectile dysfunction was found in 47{\%} and 75{\%} of the cases, respectively. Conclusions. Preoperative SC-RT combined with chemotherapy for locally advanced resectable rectal cancers was well tolerated. This treatment resulted in favourable LC, OS, low rates of toxicity and satisfying QoL.",
keywords = "Combined chemo-radiation therapy, Preoperative short-course radiation therapy, Rectal cancer",
author = "Patrizia Ciammella and Ruggieri, {Maria Paola} and Maria Galeandro and Nunziata D'Abbiero and Alessandro Giunta and Cinzia Iotti",
year = "2013",
month = "12",
doi = "10.1007/s11547-013-0939-6",
language = "Italian",
volume = "118",
pages = "1397--1411",
journal = "Radiologia Medica",
issn = "0033-8362",
publisher = "Springer-Verlag Italia s.r.l.",
number = "8",

}

TY - JOUR

T1 - Radioterapia ipofrazionata short-course neoadiuvante in associazione alla chemioterapia nelle neoplasie rettali operabili in stadio localmente avanzato

T2 - Controllo locale e qualità di vita

AU - Ciammella, Patrizia

AU - Ruggieri, Maria Paola

AU - Galeandro, Maria

AU - D'Abbiero, Nunziata

AU - Giunta, Alessandro

AU - Iotti, Cinzia

PY - 2013/12

Y1 - 2013/12

N2 - Purpose. The authors sought to evaluate the clinical outcome after preoperative short-course radiotherapy (SCRT) for locally advanced resectable rectal cancer in terms of local control (LC) and quality of life (QoL). Materials and methods. Patients with locally advanced rectal cancer enrolled between 1997 and 2008 in an observational study of preoperative SC-RT were analysed. The treatment algorithm was neo-adjuvant chemotherapy (CT) administered for four cycles, followed by preoperative SC-RT administered 1 week after chemotherapy completion, delivering 20 Gy in five fractions over 1 week. Immediately in the following week surgery was performed. The adjuvant 5-FU-based CT was planned for pathological stage UICC≥II. LC, overall survival (OS), disease-free survival (DFS), early and late complications (RTOG scale) were analysed. All patients completed the EORTC QoL (C-30 and C-38), Faecal Incontinence QoL, and International Index of Erectile Function questionnaires (IIEF). Results. A total of 67 patients were analysed. Chemotherapy and radiotherapy were well tolerated. At the pathological analysis, stable disease was obtained in 24 patients (36%), reduction of disease stage in 34 patients (50.7%), and progression in nine cases (13.3%). Adjuvant chemotherapy was indicated in 21 patients. Two locoregional recurrences, both within the radiotherapy ipovolume, were observed, resulting in a 5-year LC of 97%. The 5-year DFS was 84%, with mean time to systemic progression of 24 months. After a mean follow-up of 114 months, the 5-year OS rate was 67%. Late toxicity >grade II was observed in 9% of patients. High anterior resection (AR) patients had significantly better scores than low AR or abdomino-perineal resection (APR). A total of 89% of the patients treated with conservative surgery had regular anal sphincter function. In male patients undergoing AR or APR, erectile dysfunction was found in 47% and 75% of the cases, respectively. Conclusions. Preoperative SC-RT combined with chemotherapy for locally advanced resectable rectal cancers was well tolerated. This treatment resulted in favourable LC, OS, low rates of toxicity and satisfying QoL.

AB - Purpose. The authors sought to evaluate the clinical outcome after preoperative short-course radiotherapy (SCRT) for locally advanced resectable rectal cancer in terms of local control (LC) and quality of life (QoL). Materials and methods. Patients with locally advanced rectal cancer enrolled between 1997 and 2008 in an observational study of preoperative SC-RT were analysed. The treatment algorithm was neo-adjuvant chemotherapy (CT) administered for four cycles, followed by preoperative SC-RT administered 1 week after chemotherapy completion, delivering 20 Gy in five fractions over 1 week. Immediately in the following week surgery was performed. The adjuvant 5-FU-based CT was planned for pathological stage UICC≥II. LC, overall survival (OS), disease-free survival (DFS), early and late complications (RTOG scale) were analysed. All patients completed the EORTC QoL (C-30 and C-38), Faecal Incontinence QoL, and International Index of Erectile Function questionnaires (IIEF). Results. A total of 67 patients were analysed. Chemotherapy and radiotherapy were well tolerated. At the pathological analysis, stable disease was obtained in 24 patients (36%), reduction of disease stage in 34 patients (50.7%), and progression in nine cases (13.3%). Adjuvant chemotherapy was indicated in 21 patients. Two locoregional recurrences, both within the radiotherapy ipovolume, were observed, resulting in a 5-year LC of 97%. The 5-year DFS was 84%, with mean time to systemic progression of 24 months. After a mean follow-up of 114 months, the 5-year OS rate was 67%. Late toxicity >grade II was observed in 9% of patients. High anterior resection (AR) patients had significantly better scores than low AR or abdomino-perineal resection (APR). A total of 89% of the patients treated with conservative surgery had regular anal sphincter function. In male patients undergoing AR or APR, erectile dysfunction was found in 47% and 75% of the cases, respectively. Conclusions. Preoperative SC-RT combined with chemotherapy for locally advanced resectable rectal cancers was well tolerated. This treatment resulted in favourable LC, OS, low rates of toxicity and satisfying QoL.

KW - Combined chemo-radiation therapy

KW - Preoperative short-course radiation therapy

KW - Rectal cancer

UR - http://www.scopus.com/inward/record.url?scp=84892931320&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892931320&partnerID=8YFLogxK

U2 - 10.1007/s11547-013-0939-6

DO - 10.1007/s11547-013-0939-6

M3 - Articolo

C2 - 23801387

AN - SCOPUS:84892931320

VL - 118

SP - 1397

EP - 1411

JO - Radiologia Medica

JF - Radiologia Medica

SN - 0033-8362

IS - 8

ER -